» Articles » PMID: 8635662

Glucagon-like Peptide I Receptors in the Subfornical Organ and the Area Postrema Are Accessible to Circulating Glucagon-like Peptide I

Overview
Journal Diabetes
Specialty Endocrinology
Date 1996 Jun 1
PMID 8635662
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

The intestinal incretin hormone glucagon-like peptide I (GLP-I) inhibits gastric motility and secretion in normal, but not in vagotomized subjects, pointing to a centrally mediated effect. Therefore, our aim was to study the availability of rat brain GLP-I receptors to peripherally injected 125I-labeled GLP-I. The specificity of the binding was tested by co-injection of excess amounts of unlabeled GLP-I. Using light microscopical autoradiography of rat brain sections, we found specific 125I-GLP-I binding exclusively in the subfornical organ and the area postrema. This binding was abolished when an excess amount of unlabeled GLP-I was co-injected with the labeled GLP-I. We conclude that cells in the subfornical organ and the area postrema could be responsive to blood-borne GLP-I. The observed binding of peripherally administered GLP-I to the subfornical organ and the area postrema, which both have close neuroanatomical connections with hypothalamic areas involved in water and appetite homeostasis, is consistent with the potential roles of circulating GLP-I in the central regulation of appetite and autonomic functions.

Citing Articles

Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.

Duran M, Willis J, Dalvi N, Fokakis Z, Virkus S, Hardaway J Endocrinology. 2025; 166(3).

PMID: 39888375 PMC: 11850305. DOI: 10.1210/endocr/bqaf019.


Food-induced small bowel obstruction observed in a patient with inappropriate use of semaglutide.

Itoh Y, Tani M, Takahashi R, Yamamoto K Diabetol Int. 2024; 15(4):850-854.

PMID: 39469548 PMC: 11512937. DOI: 10.1007/s13340-024-00751-4.


GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management.

Holst J Nat Metab. 2024; 6(10):1866-1885.

PMID: 39160334 DOI: 10.1038/s42255-024-01113-9.


Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.

Liu Q Front Endocrinol (Lausanne). 2024; 15:1431292.

PMID: 39114288 PMC: 11304055. DOI: 10.3389/fendo.2024.1431292.


Impacts of different pancreatic resection ranges on endocrine function in .

Li R, Yang T, Zeng Y, Natsuyama Y, Ren K, Li J World J Gastrointest Surg. 2024; 16(7):2308-2318.

PMID: 39087135 PMC: 11287669. DOI: 10.4240/wjgs.v16.i7.2308.